Relenza gets a mention in Niman's latest commentary:
US Week 2 P&I Death Rate Spike Raises Concerns Recombinomics Commentary 16:00 January 19, 2013
Excerpt "the FDA waived a repackaging requirement for Tamiflu with older package inserts. The speakers also urged the public to get vaccinated and physicians to treat patients with Tamiflu (or Relenza) earlier (even if influenza had not been lab confirmed)."
Surely Biota management are lobbying GSK and the CDC/FDA to release supplies of Relenza (developed by Biota but licensed to GSK) from the US Federal stockpile?
Regards Kangaroo1
BTA Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held